Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Unlabelled: Large doses of steroids are integral to R-CHOP, a first-line systemic therapy for diffuse large B-cell lymphoma (DLBCL), an aggressive form of non-Hodgkin Lymphoma (NHL). Patients on R-CHOP often develop clinically significant hyperglycemia from steroids. There is evidence of harms from steroid-induced hyperglycemia in the context of chemotherapy which are associated with a reduction in overall survival. The objective of our study was to characterize the effect of steroid-induced hyperglycemia on the outcomes of R-CHOP chemotherapy for DLBCL.
Methods: We performed a retrospective chart review of 188 patients with DLBCL treated with R-CHOP through CancerCare Manitoba (CCMB) from 1 January 2010 to 31 December 2014. Patients diagnosed with DLBCL were identified using the Manitoba Cancer Registry. The CCMB electronic medical record was reviewed to examine the association between steroid-induced hyperglycemia and subsequent infection, including febrile neutropenic events and overall survival (OS).
Results: Patients who developed hyperglycemia with steroid exposure became hyperglycemic during their first R-CHOP cycle. No significant differences in OS or rates of infection were found between euglycemic and hyperglycemic subjects.
Conclusions: Patients destined to develop steroid-induced hyperglycemia declare themselves early in the course of steroid exposure. No statistically significant reduction in overall survival attributable to steroid-induced hyperglycemia was found.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10742719 | PMC |
| http://dx.doi.org/10.3390/curroncol30120738 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diabetes management during the end of life.
Br J Nurs
September 2025
Macmillan Palliative and End of Life Care Practice Educator and Specialist Nurse Practitioner, Northampton General Hospital.
For individuals with diabetes, maintaining optimal glycaemic control is essential to reduce the risk of long-term complications. However, as patients approach the end of life, the emphasis on tight glycaemic targets becomes less relevant. Instead, the primary goal shifts to maintaining blood glucose levels within a range that minimises the risk of hypoglycaemia and prevents symptomatic hyperglycaemia, thereby ensuring comfort and quality of life.
View Article and Find Full Text PDFSecond-Degree Atrioventricular Block With Steroid-Induced Diabetes Mellitus in a Miniature Poodle.
Vet Med Sci
September 2025
Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
An 8-year-old castrated male Miniature Poodle was referred due to polyuria, polydipsia and urinary incontinence, following 12 days of prednisolone administration (0.25 mg/kg q12h) for otitis externa. Upon physical examination, an abnormal heart rhythm was detected on cardiac auscultation without any associated clinical signs.
View Article and Find Full Text PDFPost-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes.
Biomedicines
June 2025
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Emerging evidence highlights the profound and lasting impact of severe illnesses such as COVID-19, particularly among individuals with underlying comorbidities. Patients with pre-existing conditions like diabetes mellitus (DM) are disproportionately affected, facing heightened risks of both disease exacerbation and the onset of new complications. Notably, the convergence of advanced age and DM has been consistently associated with poor COVID-19 outcomes.
View Article and Find Full Text PDFManagement of Steroid-Induced Diabetes: A Review of Herbal Medications and Their Role in Modulating Insulin Signaling Pathways.
Endocr Metab Immune Disord Drug Targets
May 2025
Department of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy)NH19 Kanpur Agra Highway, Kanpur UP, India.
Background: Steroids are pharmaceuticals that have been extensively used for the treatment of numerous medical ailments. However, they have several negative effects, one of which is hyperglycaemia or Steroid-induced diabetes. It may happen to anybody, with or without a history of diabetes.
View Article and Find Full Text PDFSlowly Progressive Type 1 Diabetes following Steroid-Sensitive Relapsing Nephrotic Syndrome in Childhood: A Case Report.
Biomed Hub
March 2025
Department of Pediatrics, NHO Matsumoto Medical Center, Matsumoto, Japan.
Introduction: In rare cases, idiopathic nephrotic syndrome (NS) and type 1 diabetes coexist, with diabetes typically preceding NS or presenting almost simultaneously with an acute onset requiring immediate insulin therapy.
Case Presentation: We report a unique case of a 5.1-year-old male who developed idiopathic NS and experienced glycosuria during steroid treatments for relapses, initially attributed to steroid-induced hyperglycemia.